Celebrating 25+ years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Cancer Research Institute

CharityWatch report issued
September 2019

Top-Rated Charity
A
CharityWatch Grade
Our independent grade based
on a number of factors.
 
84%
Program Percentage
Amount spent on programs
relative to overhead.
 
$15
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Cancer Research Institute
29 Broadway
Floor 4
New York, NY 10006-3111

Other Names

None

Tax Status

501(c)3

Stated Mission

To save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Care  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Survivors' Fund  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation  
Children's Cancer Research Fund  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation  
Good Charity  
Leukemia & Lymphoma Society  
LiveStrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 06/30/2018

Program Percentage: 84%

The percentage of Cancer Research Institute's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$31,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $15

How many dollars Cancer Research Institute spends on fundraising to raise each $100 of contributions.

$24,000,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Cancer Research Institute IRS Form 990 13-1837442
Cancer Research Institute Audited Financial Statements 13-1837442
Entity: Cancer Research Institute
Document Type: IRS Form 990
Tax ID: 13-1837442
Entity: Cancer Research Institute
Document Type: Audited Financial Statements
Tax ID: 13-1837442

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
Cancer Research Institute
meets governance benchmarks.
 
Cancer Research Institute
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Jill O'Donnell-Tormey CEO/Director of Scientific Affairs $464,756
2 Alfred R. Massidas CFO/Director of HR $348,306
3 Lynne Rapino Director, Grants Administration & Special Events $294,569
1
Name: Jill O'Donnell-Tormey
Title: CEO/Director of Scientific Affairs
Compensation: $464,756
2
Name: Alfred R. Massidas
Title: CFO/Director of HR
Compensation: $348,306
3
Name: Lynne Rapino
Title: Director, Grants Administration & Special Events
Compensation: $294,569

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the Cancer Research Institute audit of June 30, 2018 (Note A-14, Contributed services), the Institute received contributed services provided by the Institute's Scientific Advisory Council in fiscal 2018 on which it placed a total value of $501,615.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]
According to the Cancer Research Institute audit of June 30, 2018 (Note B, Contributions and Grants and Other Receivables):

"... Included in contribution revenue for fiscal-year 2018, was an amount of $6,914,717 from two donors, which represented approximately 56% of the total operating support and revenue for that fiscal year.."
According to the Cancer Research Institute audit of June 30, 2018 (Note A-13, Contributions):

"The Institute has entered into various clinical research support agreements to conduct clinical trials of cancer immunotherapies. The clinical trials are co-funded by various parties who have provided support in the amount of approximately $6,914,717 through June 30, 2018."
According to the Cancer Research Institute audit of June 30, 2018 (Note L, Financial Investment):

"In 2010, the Institute entered into a joint venture with the Ludwig Institute for Cancer Research Ltd. and formed a U.S. company named Cancer Vaccine Acceleration Company, LLC ('CVAC'). The members' initial capital contribution was $200. The purpose of the company is to obtain, hold, and develop intellectual property and other assets related to research and development of a vaccine for cancer in furtherance of the respective charitable missions of the members. The Institute believes that at present, the value of this investment is not material."

Related Articles

No related articles found